Demant A/S
Demant A/S WILYY Peers
See (WILYY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WILYY | $19.25 | N/A | 8.2B | 19.25 | $1.00 | N/A |
| SEMHF | $53.30 | -3.27% | 59.8B | 25.50 | $2.09 | +2.11% |
| SMMNY | $26.26 | +0.13% | 58.9B | 25.25 | $1.04 | +0.99% |
| RYLPF | $22.41 | -3.50% | 20.7B | 77.28 | $0.29 | +4.24% |
| SONVY | $61.28 | -1.86% | 18.3B | 28.24 | $2.17 | +1.56% |
| SONVF | $298.00 | +12.45% | 17.8B | 27.41 | $10.87 | +1.96% |
| SNNUF | $14.52 | +2.18% | 12.7B | 30.89 | $0.47 | +2.58% |
| CHEOF | $182.46 | +9.25% | 11.9B | 50.40 | $3.62 | +1.52% |
| CHEOY | $87.00 | -1.41% | 11.4B | 47.80 | $1.82 | +1.61% |
| WILLF | $36.25 | N/A | 7.5B | 18.13 | $2.00 | N/A |
Stock Comparison
WILYY vs SEMHF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SEMHF has a market cap of 59.8B. Regarding current trading prices, WILYY is priced at $19.25, while SEMHF trades at $53.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SEMHF's P/E ratio is 25.50. In terms of profitability, WILYY's ROE is +0.25%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, WILYY and SEMHF have similar daily volatility (0.00).
WILYY vs SMMNY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SMMNY has a market cap of 58.9B. Regarding current trading prices, WILYY is priced at $19.25, while SMMNY trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SMMNY's P/E ratio is 25.25. In terms of profitability, WILYY's ROE is +0.25%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, WILYY is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs RYLPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, RYLPF has a market cap of 20.7B. Regarding current trading prices, WILYY is priced at $19.25, while RYLPF trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas RYLPF's P/E ratio is 77.28. In terms of profitability, WILYY's ROE is +0.25%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, WILYY is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs SONVY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SONVY has a market cap of 18.3B. Regarding current trading prices, WILYY is priced at $19.25, while SONVY trades at $61.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SONVY's P/E ratio is 28.24. In terms of profitability, WILYY's ROE is +0.25%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, WILYY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs SONVF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SONVF has a market cap of 17.8B. Regarding current trading prices, WILYY is priced at $19.25, while SONVF trades at $298.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SONVF's P/E ratio is 27.41. In terms of profitability, WILYY's ROE is +0.25%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, WILYY and SONVF have similar daily volatility (0.00).
WILYY vs SNNUF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, WILYY is priced at $19.25, while SNNUF trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SNNUF's P/E ratio is 30.89. In terms of profitability, WILYY's ROE is +0.25%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, WILYY and SNNUF have similar daily volatility (0.00).
WILYY vs CHEOF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CHEOF has a market cap of 11.9B. Regarding current trading prices, WILYY is priced at $19.25, while CHEOF trades at $182.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CHEOF's P/E ratio is 50.40. In terms of profitability, WILYY's ROE is +0.25%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, WILYY and CHEOF have similar daily volatility (0.00).
WILYY vs CHEOY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CHEOY has a market cap of 11.4B. Regarding current trading prices, WILYY is priced at $19.25, while CHEOY trades at $87.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CHEOY's P/E ratio is 47.80. In terms of profitability, WILYY's ROE is +0.25%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, WILYY is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs WILLF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, WILYY is priced at $19.25, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas WILLF's P/E ratio is 18.13. In terms of profitability, WILYY's ROE is +0.25%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, WILYY and WILLF have similar daily volatility (0.00).
WILYY vs GNGBY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, GNGBY has a market cap of 5.2B. Regarding current trading prices, WILYY is priced at $19.25, while GNGBY trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas GNGBY's P/E ratio is 33.91. In terms of profitability, WILYY's ROE is +0.25%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, WILYY is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs AMBFF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, AMBFF has a market cap of 5.2B. Regarding current trading prices, WILYY is priced at $19.25, while AMBFF trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas AMBFF's P/E ratio is 91.43. In terms of profitability, WILYY's ROE is +0.25%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, WILYY and AMBFF have similar daily volatility (0.00).
WILYY vs GNGBF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, WILYY is priced at $19.25, while GNGBF trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas GNGBF's P/E ratio is 36.11. In terms of profitability, WILYY's ROE is +0.25%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, WILYY and GNGBF have similar daily volatility (0.00).
WILYY vs NGMDF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, NGMDF has a market cap of 4.1B. Regarding current trading prices, WILYY is priced at $19.25, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas NGMDF's P/E ratio is -4.30. In terms of profitability, WILYY's ROE is +0.25%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, WILYY and NGMDF have similar daily volatility (0.00).
WILYY vs AMBBY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, AMBBY has a market cap of 3.9B. Regarding current trading prices, WILYY is priced at $19.25, while AMBBY trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas AMBBY's P/E ratio is 71.95. In terms of profitability, WILYY's ROE is +0.25%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, WILYY and AMBBY have similar daily volatility (0.00).
WILYY vs NHNKY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, NHNKY has a market cap of 3.9B. Regarding current trading prices, WILYY is priced at $19.25, while NHNKY trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas NHNKY's P/E ratio is 20.05. In terms of profitability, WILYY's ROE is +0.25%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, WILYY is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs NHNKF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, WILYY is priced at $19.25, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, WILYY's ROE is +0.25%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, WILYY and NHNKF have similar daily volatility (0.00).
WILYY vs VTRLY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, WILYY is priced at $19.25, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, WILYY's ROE is +0.25%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, WILYY and VTRLY have similar daily volatility (0.00).
WILYY vs OSSFF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, WILYY is priced at $19.25, while OSSFF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, WILYY's ROE is +0.25%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, WILYY and OSSFF have similar daily volatility (0.00).
WILYY vs GNNDY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, WILYY is priced at $19.25, while GNNDY trades at $42.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas GNNDY's P/E ratio is 17.14. In terms of profitability, WILYY's ROE is +0.25%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, WILYY and GNNDY have similar daily volatility (0.00).
WILYY vs STSEY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, WILYY is priced at $19.25, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas STSEY's P/E ratio is 39.41. In terms of profitability, WILYY's ROE is +0.25%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, WILYY and STSEY have similar daily volatility (0.00).
WILYY vs GGNDF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, WILYY is priced at $19.25, while GGNDF trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas GGNDF's P/E ratio is 14.95. In terms of profitability, WILYY's ROE is +0.25%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, WILYY and GGNDF have similar daily volatility (0.00).
WILYY vs DWRKF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, WILYY is priced at $19.25, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, WILYY's ROE is +0.25%, compared to DWRKF's ROE of N/A. Regarding short-term risk, WILYY and DWRKF have similar daily volatility (0.00).
WILYY vs MCRPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, WILYY is priced at $19.25, while MCRPF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MCRPF's P/E ratio is -7.82. In terms of profitability, WILYY's ROE is +0.25%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, WILYY and MCRPF have similar daily volatility (0.00).
WILYY vs OSSUY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, WILYY is priced at $19.25, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, WILYY's ROE is +0.25%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, WILYY and OSSUY have similar daily volatility (0.00).
WILYY vs MEDGF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, WILYY is priced at $19.25, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, WILYY's ROE is +0.25%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, WILYY and MEDGF have similar daily volatility (0.00).
WILYY vs DRWKF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DRWKF has a market cap of 1.3B. Regarding current trading prices, WILYY is priced at $19.25, while DRWKF trades at $70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DRWKF's P/E ratio is 9.42. In terms of profitability, WILYY's ROE is +0.25%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, WILYY and DRWKF have similar daily volatility (0.00).
WILYY vs IMEXF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, IMEXF has a market cap of 1.2B. Regarding current trading prices, WILYY is priced at $19.25, while IMEXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, WILYY's ROE is +0.25%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, WILYY is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs DGWPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, WILYY is priced at $19.25, while DGWPF trades at $55.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DGWPF's P/E ratio is 7.51. In terms of profitability, WILYY's ROE is +0.25%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, WILYY and DGWPF have similar daily volatility (0.00).
WILYY vs XVIPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, WILYY is priced at $19.25, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, WILYY's ROE is +0.25%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, WILYY and XVIPF have similar daily volatility (0.00).
WILYY vs LFTSF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, WILYY is priced at $19.25, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, WILYY's ROE is +0.25%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, WILYY is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs ELEAF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, WILYY is priced at $19.25, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ELEAF's P/E ratio is 11.02. In terms of profitability, WILYY's ROE is +0.25%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, WILYY and ELEAF have similar daily volatility (0.00).
WILYY vs MDRSF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MDRSF has a market cap of 638.4M. Regarding current trading prices, WILYY is priced at $19.25, while MDRSF trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MDRSF's P/E ratio is 151.47. In terms of profitability, WILYY's ROE is +0.25%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, WILYY is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs CALZF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CALZF has a market cap of 559.8M. Regarding current trading prices, WILYY is priced at $19.25, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CALZF's P/E ratio is 81.03. In terms of profitability, WILYY's ROE is +0.25%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, WILYY and CALZF have similar daily volatility (0.00).
WILYY vs CLVSF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, WILYY is priced at $19.25, while CLVSF trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, WILYY's ROE is +0.25%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, WILYY and CLVSF have similar daily volatility (0.00).
WILYY vs LBLTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, LBLTF has a market cap of 496.1M. Regarding current trading prices, WILYY is priced at $19.25, while LBLTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas LBLTF's P/E ratio is -1.22. In terms of profitability, WILYY's ROE is +0.25%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, WILYY is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs AVMR Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, WILYY is priced at $19.25, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas AVMR's P/E ratio is -18.34. In terms of profitability, WILYY's ROE is +0.25%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, WILYY and AVMR have similar daily volatility (0.00).
WILYY vs IOBCF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, IOBCF has a market cap of 404.3M. Regarding current trading prices, WILYY is priced at $19.25, while IOBCF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas IOBCF's P/E ratio is 39.43. In terms of profitability, WILYY's ROE is +0.25%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, WILYY and IOBCF have similar daily volatility (0.00).
WILYY vs HYBT Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, WILYY is priced at $19.25, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas HYBT's P/E ratio is N/A. In terms of profitability, WILYY's ROE is +0.25%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, WILYY and HYBT have similar daily volatility (0.00).
WILYY vs EAPIF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, WILYY is priced at $19.25, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, WILYY's ROE is +0.25%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, WILYY is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs DMTRF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DMTRF has a market cap of 276.8M. Regarding current trading prices, WILYY is priced at $19.25, while DMTRF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DMTRF's P/E ratio is -35.86. In terms of profitability, WILYY's ROE is +0.25%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, WILYY is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs CSSPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, WILYY is priced at $19.25, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, WILYY's ROE is +0.25%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, WILYY is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs HTLZF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, WILYY is priced at $19.25, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, WILYY's ROE is +0.25%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, WILYY and HTLZF have similar daily volatility (0.00).
WILYY vs CLLKF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CLLKF has a market cap of 241.8M. Regarding current trading prices, WILYY is priced at $19.25, while CLLKF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CLLKF's P/E ratio is -7.78. In terms of profitability, WILYY's ROE is +0.25%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, WILYY and CLLKF have similar daily volatility (0.00).
WILYY vs CYBQY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CYBQY has a market cap of 216.3M. Regarding current trading prices, WILYY is priced at $19.25, while CYBQY trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CYBQY's P/E ratio is -50.50. In terms of profitability, WILYY's ROE is +0.25%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, WILYY and CYBQY have similar daily volatility (0.00).
WILYY vs CYBQF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, WILYY is priced at $19.25, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, WILYY's ROE is +0.25%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, WILYY and CYBQF have similar daily volatility (0.00).
WILYY vs BCCOY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, BCCOY has a market cap of 172.6M. Regarding current trading prices, WILYY is priced at $19.25, while BCCOY trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas BCCOY's P/E ratio is -5.68. In terms of profitability, WILYY's ROE is +0.25%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, WILYY and BCCOY have similar daily volatility (0.00).
WILYY vs BRNHF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, WILYY is priced at $19.25, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, WILYY's ROE is +0.25%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, WILYY is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs EKDHF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, EKDHF has a market cap of 161.7M. Regarding current trading prices, WILYY is priced at $19.25, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, WILYY's ROE is +0.25%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, WILYY is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs JMDMF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, JMDMF has a market cap of 157.9M. Regarding current trading prices, WILYY is priced at $19.25, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, WILYY's ROE is +0.25%, compared to JMDMF's ROE of N/A. Regarding short-term risk, WILYY is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs AVHHL Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, AVHHL has a market cap of 149.9M. Regarding current trading prices, WILYY is priced at $19.25, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, WILYY's ROE is +0.25%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, WILYY and AVHHL have similar daily volatility (0.00).
WILYY vs BRSYF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, WILYY is priced at $19.25, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, WILYY's ROE is +0.25%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, WILYY is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs VMTHF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, WILYY is priced at $19.25, while VMTHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, WILYY's ROE is +0.25%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, WILYY and VMTHF have similar daily volatility (0.00).
WILYY vs AMEUF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, WILYY is priced at $19.25, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, WILYY's ROE is +0.25%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, WILYY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs PXMBF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, PXMBF has a market cap of 120.5M. Regarding current trading prices, WILYY is priced at $19.25, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, WILYY's ROE is +0.25%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, WILYY is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs FDMDF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, WILYY is priced at $19.25, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, WILYY's ROE is +0.25%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, WILYY and FDMDF have similar daily volatility (0.00).
WILYY vs IMPZY Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, IMPZY has a market cap of 100M. Regarding current trading prices, WILYY is priced at $19.25, while IMPZY trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas IMPZY's P/E ratio is -0.80. In terms of profitability, WILYY's ROE is +0.25%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, WILYY is less volatile compared to IMPZY. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs TCLIF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, TCLIF has a market cap of 96.4M. Regarding current trading prices, WILYY is priced at $19.25, while TCLIF trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas TCLIF's P/E ratio is -23.11. In terms of profitability, WILYY's ROE is +0.25%, compared to TCLIF's ROE of -0.74%. Regarding short-term risk, WILYY is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs RSHUF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, WILYY is priced at $19.25, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, WILYY's ROE is +0.25%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, WILYY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs CKMTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, WILYY is priced at $19.25, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, WILYY's ROE is +0.25%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, WILYY and CKMTF have similar daily volatility (0.00).
WILYY vs SOMNF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SOMNF has a market cap of 79.4M. Regarding current trading prices, WILYY is priced at $19.25, while SOMNF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SOMNF's P/E ratio is -12.25. In terms of profitability, WILYY's ROE is +0.25%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, WILYY is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs SNZZF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, SNZZF has a market cap of 73.2M. Regarding current trading prices, WILYY is priced at $19.25, while SNZZF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas SNZZF's P/E ratio is -5.00. In terms of profitability, WILYY's ROE is +0.25%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, WILYY and SNZZF have similar daily volatility (0.00).
WILYY vs IPDQF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, IPDQF has a market cap of 68.1M. Regarding current trading prices, WILYY is priced at $19.25, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas IPDQF's P/E ratio is -3.36. In terms of profitability, WILYY's ROE is +0.25%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, WILYY and IPDQF have similar daily volatility (0.00).
WILYY vs RDGL Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, RDGL has a market cap of 58M. Regarding current trading prices, WILYY is priced at $19.25, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas RDGL's P/E ratio is -12.78. In terms of profitability, WILYY's ROE is +0.25%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, WILYY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs BLOZF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, BLOZF has a market cap of 49.9M. Regarding current trading prices, WILYY is priced at $19.25, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas BLOZF's P/E ratio is -21.68. In terms of profitability, WILYY's ROE is +0.25%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, WILYY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs CRRVF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, CRRVF has a market cap of 46.3M. Regarding current trading prices, WILYY is priced at $19.25, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, WILYY's ROE is +0.25%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, WILYY is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs NVYTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, WILYY is priced at $19.25, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, WILYY's ROE is +0.25%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, WILYY is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs TLTFF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, TLTFF has a market cap of 34.7M. Regarding current trading prices, WILYY is priced at $19.25, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas TLTFF's P/E ratio is -14.00. In terms of profitability, WILYY's ROE is +0.25%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, WILYY and TLTFF have similar daily volatility (0.00).
WILYY vs ELXMF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, WILYY is priced at $19.25, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, WILYY's ROE is +0.25%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, WILYY and ELXMF have similar daily volatility (0.00).
WILYY vs POSC Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, POSC has a market cap of 24.7M. Regarding current trading prices, WILYY is priced at $19.25, while POSC trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas POSC's P/E ratio is 0.37. In terms of profitability, WILYY's ROE is +0.25%, compared to POSC's ROE of +9.25%. Regarding short-term risk, WILYY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs PLLWF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, WILYY is priced at $19.25, while PLLWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, WILYY's ROE is +0.25%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, WILYY and PLLWF have similar daily volatility (0.00).
WILYY vs KBBTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, WILYY is priced at $19.25, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, WILYY's ROE is +0.25%, compared to KBBTF's ROE of N/A. Regarding short-term risk, WILYY and KBBTF have similar daily volatility (0.00).
WILYY vs EMITF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, EMITF has a market cap of 22.2M. Regarding current trading prices, WILYY is priced at $19.25, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas EMITF's P/E ratio is -14.29. In terms of profitability, WILYY's ROE is +0.25%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, WILYY and EMITF have similar daily volatility (0.00).
WILYY vs ASAPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ASAPF has a market cap of 18.5M. Regarding current trading prices, WILYY is priced at $19.25, while ASAPF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ASAPF's P/E ratio is -23.65. In terms of profitability, WILYY's ROE is +0.25%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, WILYY and ASAPF have similar daily volatility (0.00).
WILYY vs MDXHF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MDXHF has a market cap of 17.6M. Regarding current trading prices, WILYY is priced at $19.25, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, WILYY's ROE is +0.25%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, WILYY and MDXHF have similar daily volatility (0.00).
WILYY vs DIZTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DIZTF has a market cap of 16.1M. Regarding current trading prices, WILYY is priced at $19.25, while DIZTF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DIZTF's P/E ratio is -10.00. In terms of profitability, WILYY's ROE is +0.25%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, WILYY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs PYNKF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, PYNKF has a market cap of 15M. Regarding current trading prices, WILYY is priced at $19.25, while PYNKF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas PYNKF's P/E ratio is -0.76. In terms of profitability, WILYY's ROE is +0.25%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, WILYY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs VPTDF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, VPTDF has a market cap of 14.5M. Regarding current trading prices, WILYY is priced at $19.25, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas VPTDF's P/E ratio is -4.45. In terms of profitability, WILYY's ROE is +0.25%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, WILYY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs TMDIF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, WILYY is priced at $19.25, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, WILYY's ROE is +0.25%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, WILYY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs ZMSPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ZMSPF has a market cap of 12.3M. Regarding current trading prices, WILYY is priced at $19.25, while ZMSPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ZMSPF's P/E ratio is N/A. In terms of profitability, WILYY's ROE is +0.25%, compared to ZMSPF's ROE of +0.82%. Regarding short-term risk, WILYY is less volatile compared to ZMSPF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs ATBPF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, WILYY is priced at $19.25, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, WILYY's ROE is +0.25%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, WILYY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs LXXGF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, WILYY is priced at $19.25, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, WILYY's ROE is +0.25%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, WILYY and LXXGF have similar daily volatility (0.00).
WILYY vs ALRTF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ALRTF has a market cap of 11.1M. Regarding current trading prices, WILYY is priced at $19.25, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ALRTF's P/E ratio is -0.58. In terms of profitability, WILYY's ROE is +0.25%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, WILYY is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs GTHP Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, GTHP has a market cap of 11M. Regarding current trading prices, WILYY is priced at $19.25, while GTHP trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas GTHP's P/E ratio is -2.80. In terms of profitability, WILYY's ROE is +0.25%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, WILYY and GTHP have similar daily volatility (0.00).
WILYY vs MKEAF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MKEAF has a market cap of 10.8M. Regarding current trading prices, WILYY is priced at $19.25, while MKEAF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MKEAF's P/E ratio is -6.11. In terms of profitability, WILYY's ROE is +0.25%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, WILYY is less volatile compared to MKEAF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs RMSL Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, RMSL has a market cap of 10.6M. Regarding current trading prices, WILYY is priced at $19.25, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas RMSL's P/E ratio is 0.69. In terms of profitability, WILYY's ROE is +0.25%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, WILYY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs DTXMF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, WILYY is priced at $19.25, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, WILYY's ROE is +0.25%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, WILYY is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs TBRIF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, TBRIF has a market cap of 5.7M. Regarding current trading prices, WILYY is priced at $19.25, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas TBRIF's P/E ratio is -1.25. In terms of profitability, WILYY's ROE is +0.25%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, WILYY is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs IRME Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, IRME has a market cap of 5.5M. Regarding current trading prices, WILYY is priced at $19.25, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas IRME's P/E ratio is -2.57. In terms of profitability, WILYY's ROE is +0.25%, compared to IRME's ROE of +11.77%. Regarding short-term risk, WILYY is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs QLIS Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, WILYY is priced at $19.25, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas QLIS's P/E ratio is 2.22. In terms of profitability, WILYY's ROE is +0.25%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, WILYY and QLIS have similar daily volatility (0.00).
WILYY vs RHNMF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, WILYY is priced at $19.25, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, WILYY's ROE is +0.25%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, WILYY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs NUMD Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, NUMD has a market cap of 4.8M. Regarding current trading prices, WILYY is priced at $19.25, while NUMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas NUMD's P/E ratio is 5.70. In terms of profitability, WILYY's ROE is +0.25%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, WILYY is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs MICR Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, WILYY is priced at $19.25, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas MICR's P/E ratio is -3.47. In terms of profitability, WILYY's ROE is +0.25%, compared to MICR's ROE of -0.25%. Regarding short-term risk, WILYY is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs FZMD Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, FZMD has a market cap of 4.7M. Regarding current trading prices, WILYY is priced at $19.25, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas FZMD's P/E ratio is 1.26. In terms of profitability, WILYY's ROE is +0.25%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, WILYY and FZMD have similar daily volatility (0.00).
WILYY vs VYCO Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, VYCO has a market cap of 3.9M. Regarding current trading prices, WILYY is priced at $19.25, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas VYCO's P/E ratio is -11.79. In terms of profitability, WILYY's ROE is +0.25%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, WILYY is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs ADMT Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ADMT has a market cap of 3.8M. Regarding current trading prices, WILYY is priced at $19.25, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ADMT's P/E ratio is -5.63. In terms of profitability, WILYY's ROE is +0.25%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, WILYY is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs ESMC Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, ESMC has a market cap of 3.4M. Regarding current trading prices, WILYY is priced at $19.25, while ESMC trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas ESMC's P/E ratio is 9.16. In terms of profitability, WILYY's ROE is +0.25%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, WILYY and ESMC have similar daily volatility (0.00).
WILYY vs VANIW Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, WILYY is priced at $19.25, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas VANIW's P/E ratio is N/A. In terms of profitability, WILYY's ROE is +0.25%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, WILYY is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.
WILYY vs PMEDF Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, PMEDF has a market cap of 3.1M. Regarding current trading prices, WILYY is priced at $19.25, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas PMEDF's P/E ratio is -2.03. In terms of profitability, WILYY's ROE is +0.25%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, WILYY and PMEDF have similar daily volatility (0.00).
WILYY vs BIEL Comparison
WILYY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WILYY stands at 8.2B. In comparison, BIEL has a market cap of 2.9M. Regarding current trading prices, WILYY is priced at $19.25, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WILYY currently has a P/E ratio of 19.25, whereas BIEL's P/E ratio is N/A. In terms of profitability, WILYY's ROE is +0.25%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, WILYY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for WILYY.